Crystal's Coder Hub🧬 ICD 10-CM R59.1 — Generalized Enlarged Lymph Nodes
Billable Code Confirmed
ICD-10-CM R59.1 is a valid, billable 4-character diagnosis code for FY2026.1 The code is complete at four characters. It does not require any additional characters for laterality or anatomical site, as it inherently describes a systemic or multi-site clinical finding.
Non-Billable Parent Codes — Never Submit These
- ❌
R59— 3-character header — Lacks specificity regarding the extent of the lymphadenopathy (localized vs. generalized).Always submit R59.1 when the provider explicitly documents “generalized” lymphadenopathy or notes enlarged lymph nodes in two or more non-contiguous anatomical regions.
Clinical Context: Symptom vs. Definitive Diagnosis
ICD-10-CM R59.1 captures the clinical sign of systemic lymph node enlargement. Official coding guidelines state that symptom codes (Chapter 18) should not be used as the principal diagnosis when a related definitive diagnosis has been established. If the generalized lymphadenopathy is determined to be caused by diffuse large B-cell lymphoma (e.g., C83.39), the lymphoma code is sequenced instead.1
Code Classification
ICD-10-CM Diagnosis Code — wRVU, assistant payable, and global period fields are not applicable; direct reader to the Commonly Associated CPT Codes section for procedural equivalents and values.
🔍 Code Description
ICD-10 CM R59.1 classifies Generalized enlarged lymph nodes. It is used when a patient presents with abnormal swelling or enlargement of lymph nodes in multiple, non-contiguous areas of the body (e.g., cervical, axillary, and inguinal nodes simultaneously).
Pathophysiologically, generalized lymphadenopathy suggests a systemic response rather than a localized infection. It is frequently driven by systemic viral infections (like HIV or Epstein-Barr virus), autoimmune diseases (such as systemic lupus erythematosus), or disseminated malignancies (such as leukemias or lymphomas). The code serves as a crucial placeholder for establishing medical necessity during the diagnostic workup phase before a definitive etiology is found.
🌳 Code Tree / Hierarchy
R50-R69 General symptoms and signs ❌ Non-billable
│
├── R59 Enlarged lymph nodes ❌ Non-billable
│ │
│ ├── R59.0 Localized enlarged lymph nodes ✅ Billable
│ ├── R59.1 Generalized enlarged lymph nodes ◀ THIS CODE ✅ Billable
│ └── R59.9 Enlarged lymph nodes, unspecified ✅ BillableSpecificity and Diagnostic Workup
Ensure documentation explicitly states “generalized” or describes enlargement in multiple disparate regions (e.g., “axillary and inguinal”) to justify R59.1 over the localized R59.0 or unspecified R59.9 codes. This distinction frequently supports the medical necessity for broader systemic laboratory panels and whole-body imaging (e.g., PET scans).
✅ Includes
The following clinical terms and scenarios map to R59.1 when documented:
- Generalized lymphadenopathy
- Palpable lymph nodes in multiple (≥2) non-contiguous regions
- Diffuse lymph node enlargement
- Systemic swollen glands
❌ Excludes
Excludes 1 — Cannot Be Coded Simultaneously with R59.1
| Code | Description | Note |
|---|---|---|
| I88.9 | Nonspecific lymphadenitis, unspecified | Lymphadenitis indicates confirmed inflammation/infection of the node itself, superseding the simple “enlarged” symptom code. |
| I88.1 | Chronic lymphadenitis, except mesenteric | Represents a definitive chronic inflammatory condition of the nodes. |
Excludes 1 Violation Risk
A common error occurs when a pathology report returns showing “chronic lymphadenitis.” If the provider updates the diagnosis to chronic lymphadenitis, you must code I88.1 and drop the symptom code R59.1. Coding both simultaneously violates Excludes 1 logic.
Excludes 2 — May Be Coded in Addition if Separately Present
(No specific Excludes 2 notes apply directly to R59.1 that override standard symptom-versus-disease guidelines).
📋 Clinical Overview
Phenotype Distinction
Understanding the difference in extent is necessary to assign the correct code from the R59 category.
| Feature | R59.1 — Generalized | R59.0 — Localized |
|---|---|---|
| Anatomical Extent | Enlargement in 2 or more non-contiguous node regions. | Enlargement confined to a single region (e.g., only cervical). |
| Clinical Implication | Suggests systemic illness (viral, autoimmune, malignancy). | Suggests regional infection or local tumor drainage. |
| Diagnostic Pathway | Often requires extensive labs, flow cytometry, or excisional biopsy. | Often evaluated with targeted ultrasound or FNA. |
CDI Query Trigger — Extent Unclear
If a provider’s physical exam notes “swollen nodes” but the assessment simply states “Lymphadenopathy,” query the provider: “Please clarify if the lymphadenopathy is localized to a specific region or generalized, to allow for the most specific symptom code assignment.”
Common Diagnoses / Clinical Indications
While R59.1 is a symptom, it frequently triggers evaluations that lead to:
- Systemic Viral Infections: e.g., Mononucleosis, HIV.
- Autoimmune Disorders: e.g., Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis.
- Hematologic Malignancies: e.g., Non-Hodgkin lymphoma, Leukemia.
Coding Manifestations
If a definitive diagnosis is known to be causing the generalized lymphadenopathy, code the definitive condition instead. For example:
- B20 — Human immunodeficiency virus [HIV] disease
- C83.39 — Diffuse large B-cell lymphoma, extranodal and solid organ sites
💰 HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | ❌ Not HCC-Mapped |
| HCC Category | N/A |
| RAF Coefficient | N/A |
R59.1 does not map to an HCC under v28.4
Capture Annually
As a symptom code, it does not directly impact RAF scores. However, the diagnostic workup it justifies often leads to the discovery of high-weight HCC conditions (e.g., lymphomas, HIV).
🏥 DRG Assignment
MDC 16 — Diseases and Disorders of Blood, Blood Forming Organs, Immunologic Disorders
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 814 | Reticuloendothelial and immunity disorders with MCC | ~1.65 - 1.85 |
| DRG 815 | Reticuloendothelial and immunity disorders with CC | ~0.90 - 1.05 |
| DRG 816 | Reticuloendothelial and immunity disorders without CC/MCC | ~0.65 - 0.75 |
Approximate. Verify against IPPS FY2026 Final Rule tables.5
Sequencing and Complications
Symptom codes like R59.1 are rarely sequenced as the principal diagnosis for an inpatient admission unless the patient is admitted purely for diagnostic workup (e.g., surgical biopsy) and discharged before the pathology results return to provide a definitive diagnosis.
🔗 Related ICD-10-CM Codes
Extent Variants
| Code | Description |
|---|---|
| R59.1 | Generalized enlarged lymph nodes ← This Code |
| R59.0 | Localized enlarged lymph nodes |
| R59.9 | Enlarged lymph nodes, unspecified |
Related Definitive Diagnoses
| Code | Description |
|---|---|
| I88.1 | Chronic lymphadenitis, except mesenteric |
| C84.Z9 | Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
🛠️ Commonly Associated CPT Codes (Outpatient / Profee)
Outpatient and Profee Setting Context
Generalized lymphadenopathy frequently establishes medical necessity for diagnostic tissue sampling, which ranges from needle aspirations to full open excisions for flow cytometry.
| CPT Code | Description | Profee Coding Notes |
|---|---|---|
| 38500 | Biopsy or excision of lymph node(s); open, superficial | Billable when a discrete node is removed via incision. |
| 38505 | Biopsy or excision of lymph node(s); by needle, superficial (eg, cervical, inguinal, axillary) | Frequently performed under ultrasound guidance (bill imaging separately if utilized). |
| 38510 | Biopsy or excision of lymph node(s); open, deep cervical node(s) | Requires deeper dissection than 38500. |
| 38520 | Biopsy or excision of lymph node(s); open, deep cervical node(s) with excision scalene fat pad | More extensive regional sampling. |
NCCI Bundling Considerations
- Multiple Biopsies: If open biopsies (38500) are performed on superficial nodes in entirely separate anatomical regions (e.g., one axillary and one inguinal) to evaluate the generalized nature of the disease, append modifier -59 or -XS to the subsequent procedures to prevent inappropriate bundling.
🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)
When R59.1 is an inpatient diagnosis pending definitive pathology, these PCS codes reflect the associated diagnostic sampling.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 (Medical and Surgical) | 7 (Lymphatic and Hemic Systems) | B (Excision) | Open biopsy of an axillary lymph node; e.g., 07B50ZX (Excision of Axillary Lymphatic, Open Approach, Diagnostic). |
| 0 (Medical and Surgical) | 7 (Lymphatic and Hemic Systems) | B (Excision) | Needle biopsy of a cervical lymph node; e.g., 07B23ZX (Excision of Neck Lymphatic, Percutaneous Approach, Diagnostic). |
💊 Coding Scenarios and Examples
Scenario 1 — Outpatient Clinic: Diagnostic Workup
Clinical Vignette: A 45-year-old male presents with a 3-week history of fatigue, night sweats, and palpable, painless lumps in his neck, armpits, and groin. The physician notes generalized lymphadenopathy on physical exam and orders an extensive infectious and hematologic lab panel, along with a referral to general surgery for an excisional node biopsy to rule out lymphoma.
CPT / HCPCS (Profee):
- 99214 — Office or other outpatient visit for the evaluation and management of an established patient, moderate MDM
ICD-10-CM:
- R59.1 — Generalized enlarged lymph nodes (Appropriate primary diagnosis as the etiology is not yet known)
- R53.83 — Other fatigue
- R61 — Generalized hyperhidrosis (Used for night sweats)
Scenario 2 — Inpatient Admission: Excisional Biopsy
Clinical Vignette: A patient with profound generalized lymphadenopathy and weight loss is admitted for an expedited open biopsy of a deep cervical lymph node. The patient is discharged the following day in stable condition. At the time of discharge coding, the pathology report is still pending.
Principal Diagnosis:
- R59.1 — Generalized enlarged lymph nodes (Sequenced as principal because the definitive diagnosis from pathology was not available at the time of coding/discharge)
Secondary Diagnoses:
- R63.4 — Abnormal weight loss
MS-DRG Assignment: Groups to DRG 816 (Reticuloendothelial and immunity disorders without CC/MCC).
Scenario 3 — CDI Query: Definitive Diagnosis Established
Clinical Vignette: The patient from Scenario 2 has their chart coded three days later. The pathology report has returned and is in the medical record, showing “Classic Hodgkin lymphoma, nodular sclerosis type.” However, the discharge summary only lists “Generalized Lymphadenopathy.”
Action / Outcome: Because a definitive pathology finding is now present in the chart, the coder cannot simply ignore it, but cannot code from the pathology report alone without the attending provider’s clinical correlation.
Query Response: The provider is queried to correlate the pathology findings with the admission diagnosis. The provider adds an addendum to the discharge summary: “Generalized lymphadenopathy due to nodular sclerosis Hodgkin lymphoma.”
Corrected ICD-10-CM Coding:
- C81.10 — Nodular sclerosis Hodgkin lymphoma, unspecified site (The definitive diagnosis replaces the symptom code R59.1 per ICD-10-CM guidelines)
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | Coding Symptom with Definitive Disease. Do not code R59.1 if the provider has established a definitive diagnosis (like lymphoma or HIV) that routinely causes generalized lymphadenopathy, unless the lymphadenopathy is completely unrelated to the primary disease. |
| ❌ | Defaulting to Unspecified. Using the unspecified code (R59.9) when the documentation clearly describes multiple affected regions (e.g., “cervical, axillary, and inguinal nodes are palpable”) under-represents the systemic nature of the patient’s presentation. |
| ✅ | Query for Pathology Results. For inpatient coding, if a biopsy was performed, always check to see if the pathology report has finalized before dropping the claim. If it has, query the provider to update the discharge diagnosis to the definitive finding, drastically changing the DRG assignment. |
| ✅ | Establish Medical Necessity. In the outpatient setting, ensure R59.1 is clearly linked to the orders for biopsies or advanced imaging (PET/CT), as payers require highly specific diagnosis codes to authorize these expensive diagnostic pathways. |
📚 Sources
1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. 2. American Hospital Association (AHA). Coding Clinic for ICD-10-CM/PCS, First Quarter 2017 Page: 24. (Guidance on symptom coding vs definitive diagnosis). 3. National Cancer Institute (NCI). (2025). Diagnostic Evaluation of Lymphadenopathy. 4. CMS. 2025-2026 Medicare Advantage Risk Adjustment — CMS-HCC Model v28 ICD-10-CM Mappings. 5. CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 16 logic tables.